FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

38741411000001104: Magnesium glycerophosphate (magnesium 97.2mg (4mmol)) chewable tablets (Alliance Healthcare (Distribution) Ltd) 50 tablet (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 05-Aug 2020. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1504561000001117 Magnesium glycerophosphate (magnesium 97.2mg (4mmol)) chewable tablets (Alliance Healthcare (Distribution) Ltd) 50 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1504571000001110 Magnesium glycerophosphate (magnesium 97.2mg (4mmol)) chewable tablets (Alliance Healthcare (Distribution) Ltd) 50 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Magnesium glycerophosphate (magnesium 97.2mg (4mmol)) chewable tablets (Alliance Healthcare (Distribution) Ltd) 50 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Magnesium glycerophosphate (magnesium 97.2mg (4mmol)) chewable tablets (Alliance Healthcare (Distribution) Ltd) 50 tablet Is a Magnesium glycerophosphate (magnesium 97.2mg (4mmol)) chewable tablets 50 tablet true Inferred relationship Existential restriction modifier
Magnesium glycerophosphate (magnesium 97.2mg (4mmol)) chewable tablets (Alliance Healthcare (Distribution) Ltd) 50 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Magnesium glycerophosphate (magnesium 97.2mg (4mmol)) chewable tablets (Alliance Healthcare (Distribution) Ltd) 50 tablet Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Magnesium glycerophosphate (magnesium 97.2mg (4mmol)) chewable tablets (Alliance Healthcare (Distribution) Ltd) 50 tablet Has AMP Magnesium glycerophosphate (magnesium 97.2mg (4mmol)) chewable tablets (Alliance Healthcare (Distribution) Ltd) true Inferred relationship Existential restriction modifier
Magnesium glycerophosphate (magnesium 97.2mg (4mmol)) chewable tablets (Alliance Healthcare (Distribution) Ltd) 50 tablet Has dispensed dose form Conventional release chewable tablet true Inferred relationship Existential restriction modifier
Magnesium glycerophosphate (magnesium 97.2mg (4mmol)) chewable tablets (Alliance Healthcare (Distribution) Ltd) 50 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Magnesium glycerophosphate (magnesium 97.2mg (4mmol)) chewable tablets (Alliance Healthcare (Distribution) Ltd) 50 tablet Has specific active ingredient Magnesium glycerophosphate true Inferred relationship Existential restriction modifier
Magnesium glycerophosphate (magnesium 97.2mg (4mmol)) chewable tablets (Alliance Healthcare (Distribution) Ltd) 50 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Magnesium glycerophosphate (magnesium 97.2mg (4mmol)) chewable tablets (Alliance Healthcare (Distribution) Ltd) 50 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Magnesium glycerophosphate (magnesium 97.2mg (4mmol)) chewable tablets (Alliance Healthcare (Distribution) Ltd) 50 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Magnesium true Inferred relationship Existential restriction modifier
Magnesium glycerophosphate (magnesium 97.2mg (4mmol)) chewable tablets (Alliance Healthcare (Distribution) Ltd) 50 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Magnesium glycerophosphate (magnesium 97.2mg (4mmol)) chewable tablets (Alliance Healthcare (Distribution) Ltd) 50 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start